Amgen (AMGN) Revenue (2009 - 2026)

Amgen (AMGN) has reported Revenue for 18 consecutive years, with $8.6 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue rose 5.76% year-over-year to $8.6 billion; the TTM figure through Mar 2026 stood at $37.2 billion (up 9.07% YoY), while the FY2025 annual figure was $36.8 billion, up 9.95% from the prior year.
• Revenue came in at $8.6 billion for Q1 2026 at Amgen, down from $9.9 billion in the prior quarter.
• The five-year high for Revenue was $9.9 billion in Q4 2025, with the low at $459.0 million in Q4 2022.
• Average Revenue over 5 years is $7.5 billion, with a median of $8.1 billion recorded in 2025.
• Across the five-year window, Revenue slumped 93.3% in 2022 and surged 1685.62% in 2023, its largest moves.
• Year by year, Revenue stood at $459.0 million in 2022, then soared by 1685.62% to $8.2 billion in 2023, then rose by 10.86% to $9.1 billion in 2024, then rose by 8.58% to $9.9 billion in 2025, then retreated by 12.65% to $8.6 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $8.6 billion, $9.9 billion, and $9.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.